OTC · INTP
Integrated Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Aug 16, 2026, 2:38 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.79K
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- — – —
- Volume
- 2K
- Avg. volume
- 0
Price performance
INTP price history
1M range · 0 trading sessions · Daily adjusted prices
INTP does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest INTP news
The latest Smart Investors Daily articles mentioning INTP.
Stock researchCompany · Overview
INTP research
Overview
Company profile and research snapshot.
Company profile
Integrated Pharmaceuticals, Inc. develops and produces specialty chemicals and nutraceuticals in the United States. It offers compounds and nutraceuticals that have proven therapeutic or nutritional value in humans, plants, and animals. The company also develops technologies for the production of clinically active pharmaceutical compounds, including active small molecules and recombinant DNA technology derived products. In addition, it offers calcium supplements that are used in soft drinks, coffee, tea, soup, dehydrated sauces, and beverages; and fortified bottled water. The company sells its products through distributors and retailers. The company was formerly known as Digital Caddies, Inc. and changed its name to Integrated Pharmaceuticals, Inc. in September 2011. The company was incorporated in 1969 and is based in Fitchburg, Massachusetts.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
